Methicillin‐resistant Staphylococcus aureous contamination of surgical wounds: Are there effective interventions?

Methicillin‐resistant Staphylococcus aureous contamination of surgical wounds: Are there effective interventions?

Surgical Site Infections (SSIs) in the US SSIs are the most common and most costly type of hospital‐acquired infection, occurring in an estimated 160,000 to 300,000 patients in the US each year.[1] SSIs increase morbidity and mortality, result in longer hospital stays and substantially increased cost of care. In fact, it has been demonstrated that…

ReliaTect® and Post-Op Risk Prevention

This 3-part series has reviewed the financial impact of SSIs  and emerging trends in SSI prevention. It is well accepted that hospital-acquired infection (HAI) after surgery or insertion of a device increases morbidity, mortality, and costs of care for patients and hospitals. Emerging trends in SSI prevention include antimicrobial dressings, with the purpose of protecting…

Antimicrobial Dressings: The Silver Mystique

As mentioned in our last posting, SSIs are the most common and costly of all hospital-acquired infections in the US.1 If you happened to have missed it, read it here. Accordingly, efforts to reduce SSI rates have led to the development of post-op dressings with antimicrobial agents impregnated within the dressing. These dressing inhibit the…